{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:39:29Z","timestamp":1788514769176,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["153556\/153044"],"award-info":[{"award-number":["153556\/153044"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5U19AI070412-06"],"award-info":[{"award-number":["5U19AI070412-06"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI007306-27"],"award-info":[{"award-number":["AI007306-27"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI095219-01"],"award-info":[{"award-number":["U19 AI095219-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL111113-02"],"award-info":[{"award-number":["K23HL111113-02"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jaci.2014.07.031","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T02:16:58Z","timestamp":1410401818000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":218,"title":["Prostaglandin D2: A\u00a0dominant mediator of aspirin-exacerbated respiratory disease"],"prefix":"10.1016","volume":"135","author":[{"given":"Katherine N.","family":"Cahill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian C.","family":"Bensko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Laidlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2014.07.031_bib1","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.rmed.2010.04.017","article-title":"Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge","volume":"104","author":"Kupczyk","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2014.07.031_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.93.06030391","article-title":"Cysteinyl leukotrienes overproduction and mast cell\u00a0activation in aspirin-provoked bronchospasm in asthma","volume":"6","author":"Sladek","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2014.07.031_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0091-6749(80)90143-8","article-title":"Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges","volume":"66","author":"Stevenson","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2014.02.041","article-title":"Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study","volume":"134","author":"Swierczynska-Krepa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib5","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1073\/pnas.90.5.2015","article-title":"Purification to homogeneity and the N-terminal sequence of human leukotriene C4 synthase: a homodimeric glutathione S-transferase composed of 18-kDa subunits","volume":"90","author":"Nicholson","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2014.07.031_bib6","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1073\/pnas.91.16.7663","article-title":"Expression cloning of a cDNA for human leukotriene C4 synthase, a novel integral membrane protein conjugating reduced glutathione to leukotriene A4","volume":"91","author":"Lam","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2014.07.031_bib7","doi-asserted-by":"crossref","first-page":"9745","DOI":"10.1073\/pnas.91.21.9745","article-title":"Molecular\u00a0cloning and expression of human leukotriene C4 synthase","volume":"91","author":"Welsch","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2014.07.031_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2222.1995.tb01079.x","article-title":"Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans","volume":"25","author":"Kumlin","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2014.07.031_bib9","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1074\/jbc.C113.453704","article-title":"Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand","volume":"288","author":"Kanaoka","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2014.07.031_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene cysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2014.07.031_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/mol.56.3.657","article-title":"Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor","volume":"56","author":"Sarau","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaci.2014.07.031_bib12","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","article-title":"Characterization of the human cysteinyl leukotriene 2 receptor","volume":"275","author":"Heise","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2014.07.031_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib14","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1081-1206(10)61101-5","article-title":"Effect of leukotriene modifier drugs on the safety of oral aspirin challenges","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pupt.2011.12.012","article-title":"PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy?","volume":"25","author":"Benyahia","year":"2012","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaci.2014.07.031_bib16","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1182\/blood-2005-07-2772","article-title":"Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses","volume":"107","author":"Feng","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2014.07.031_bib17","doi-asserted-by":"crossref","first-page":"41512","DOI":"10.1074\/jbc.M312568200","article-title":"Protein kinase A\u00a0inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523","volume":"279","author":"Luo","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2014.07.031_bib18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1152\/jappl.1989.66.4.1685","article-title":"Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction","volume":"66","author":"Beasley","year":"1989","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jaci.2014.07.031_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198407263110401","article-title":"The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men","volume":"311","author":"Hardy","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2014.07.031_bib20","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2014.07.031_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.07.031_bib22","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on T2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2332\/allergolint.11-RA-0403","article-title":"Aspirin-intolerant asthma assessment using the urinary biomarkers, leukotriene E4 and prostaglandin D2 metabolites","volume":"61","author":"Higashi","year":"2012","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2014.07.031_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A controlled study of 9\u03b1,11\u03b2-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib25","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","article-title":"Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics","volume":"154","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2014.07.031_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1081-1206(10)60692-8","article-title":"Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper","volume":"98","author":"Macy","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib27","series-title":"Expert panel report 3: guidelines for the diagnosis and management of asthma","year":"2007"},{"key":"10.1016\/j.jaci.2014.07.031_bib28","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2014.07.031_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0378-4347(93)80161-V","article-title":"Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry","volume":"612","author":"Morrow","year":"1993","journal-title":"J Chromatogr"},{"key":"10.1016\/j.jaci.2014.07.031_bib30","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/S0021-9258(18)53593-6","article-title":"Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma","volume":"268","author":"Awad","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2014.07.031_bib31","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/1523-1747.ep12606209","article-title":"Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2","volume":"104","author":"Morrow","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2014.07.031_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2014.07.031_bib33","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","article-title":"Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics","volume":"154","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2014.07.031_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1081-1206(10)62951-1","article-title":"Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma","volume":"80","author":"Yoshida","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib35","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1172\/JCI19785","article-title":"Mast cells are required for experimental oral allergen-induced diarrhea","volume":"112","author":"Brandt","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2014.07.031_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/thx.2007.080903","article-title":"Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity","volume":"63","author":"Mastalerz","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2014.07.031_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.anai.2010.05.020","article-title":"Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease","volume":"105","author":"Lee","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib38","doi-asserted-by":"crossref","first-page":"16987","DOI":"10.1073\/pnas.1313185110","article-title":"Prostaglandin E2 deficiency causes a\u00a0phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes","volume":"110","author":"Liu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2014.07.031_bib39","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI59262","article-title":"Niacin and biosynthesis of PGD(2)by platelet COX-1 in mice and humans","volume":"122","author":"Song","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2014.07.031_bib40","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1152\/jappl.1988.64.4.1567","article-title":"Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma","volume":"64","author":"Hardy","year":"1988","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jaci.2014.07.031_bib41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2332\/allergolint.O-08-545","article-title":"Correlation between the prostaglandin D(2)\/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma","volume":"57","author":"Yoshimura","year":"2008","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2014.07.031_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6989(77)80027-1","article-title":"Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps","volume":"9","author":"Szczeklik","year":"1977","journal-title":"Pharamacol Res Commun"},{"key":"10.1016\/j.jaci.2014.07.031_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4615-5325-0_28","article-title":"Interaction of PGH synthase isozymes-1 and -2 with nonsteroidal anti-inflammatory drugs","volume":"400A","author":"Smith","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaci.2014.07.031_bib44","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/thx.52.11.940","article-title":"Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma","volume":"52","author":"Sousa","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2014.07.031_bib45","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/art.10426","article-title":"The safety of celecoxib in patients with aspirin-sensitive asthma","volume":"46","author":"Woessner","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2014.07.031_bib46","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1164\/ajrccm.151.5.7735581","article-title":"The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma","volume":"151","author":"Nasser","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2014.07.031_bib47","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/ajrccm.158.4.9710043","article-title":"Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism","volume":"158","author":"Szczeklik","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2014.07.031_bib48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejphar.2011.07.046","article-title":"Prostaglandin D(2) induces contractions through activation of TP receptors in peripheral lung tissue from the guinea pig","volume":"669","author":"Larsson","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2014.07.031_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J Clin Allergy Immunol"},{"key":"10.1016\/j.jaci.2014.07.031_bib50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2125.1992.tb05649.x","article-title":"The effects\u00a0of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and\u00a0relationship to plasma drug concentrations","volume":"34","author":"Johnston","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2014.07.031_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2012.10.013","article-title":"Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients","volume":"131","author":"Busse","year":"2013","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914010306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914010306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:52:22Z","timestamp":1758790342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674914010306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0091674914010306"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2014.07.031","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostaglandin D2: A\u00a0dominant mediator of aspirin-exacerbated respiratory disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2014.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}